Literature DB >> 21029447

Correction: A cell-permeable dominant-negative survivin protein induces apoptosis and sensitizes prostate cancer cells to TNF-α therapy.

Chun Hei Antonio Cheung¹, Xueying Sun, Jagat R Kanwar, Ji-Zhong Bai, Liting Cheng, Geoffrey W Krissansen.

Abstract

Entities: Disease Gene

Year: 2010 PMID： 21029447 PMCID： PMC2987845 DOI： 10.1186/1475-2867-10-43

Source DB: PubMed Journal: Cancer Cell Int ISSN： 1475-2867 Impact factor: 5.722

× No keyword cloud information.

Correction

Since publication of our article [1], we have regrettably noticed an error. The molarities of 16, 48, 80 and 112 μg/mL solutions of dNSurR9-C84A of molecular weight 42 kDa were incorrectly given as 1, 3, 5, and 7 μM. The correct molarities which should be used throughout are 0.38, 1.1, 1.9, and 2.7 μM, respectively.

1 in total

1. A cell-permeable dominant-negative survivin protein induces apoptosis and sensitizes prostate cancer cells to TNF-α therapy.

Authors: Chun Hei Antonio Cheung; Xueying Sun; Jagat R Kanwar; Ji-Zhong Bai; Liting Cheng; Geoffrey W Krissansen
Journal: Cancer Cell Int Date: 2010-10-01 Impact factor: 5.722

1 in total

3 in total

1. Involvement of NF-κB in mediating the anti-tumour effects of combretastatins in T cells.

Authors: Jade K Pollock; Lisa M Greene; Seema M Nathwani; Paula Kinsella; Niamh M O'Boyle; Mary J Meegan; Daniela M Zisterer
Journal: Invest New Drugs Date: 2018-02-19 Impact factor: 3.850

2. Nanoformulated cell-penetrating survivin mutant and its dual actions.

Authors: Bhasker Sriramoju; Rupinder K Kanwar; Jagat R Kanwar
Journal: Int J Nanomedicine Date: 2014-07-10

Review 3. Adjunctive fecal microbiota transplantation in supportive oncology: Emerging indications and considerations in immunocompromised patients.

Authors: H R Wardill; K R Secombe; R V Bryant; M D Hazenberg; S P Costello
Journal: EBioMedicine Date: 2019-03-30 Impact factor: 8.143

3 in total